Learning Disability (Intellectual Disability) for MRCPsych Paper B

Learning disability (intellectual disability) accounts for approximately 6% of Paper B marks. The questions cover the ICD-11 classification and severity grading, behavioural phenotypes of specific genetic syndromes, the assessment and management of mental health conditions in people with LD, diagnostic overshadowing, and the legal framework (MCA, safeguarding, and the interface with forensic services). Recall documents confirm that specific syndrome presentation questions (Down syndrome, Fragile X, Rett, cri du chat, neurofibromatosis) are recurring.

ICD-11 Definition and Classification

Intellectual disability (the ICD-11 term, though “learning disability” is the preferred UK clinical term) is defined by significant impairment of intellectual functioning (IQ approximately below 70) AND significant impairment of adaptive functioning (conceptual, social, and practical skills), with onset during the developmental period (before age 18). Severity is graded by adaptive functioning, not by IQ alone:

• Mild (IQ 50-69, ~85% of LD): Can achieve academic skills up to approximately age 11-12. Able to live independently with support, hold employment, and maintain relationships. Often not diagnosed until school age.
• Moderate (IQ 35-49, ~10%): Academic skills up to approximately age 8-9. Need more support with daily living, usually live in supported accommodation. Most have identifiable genetic cause.
• Severe (IQ 20-34, ~4%): Limited language (single words, simple phrases), require support with all activities of daily living. High likelihood of comorbid physical disabilities, epilepsy, and sensory impairments.
• Profound (IQ below 20, ~1%): Minimal language, complete dependence on others for all aspects of care. High rates of physical disability, epilepsy, and medical comorbidity. Life expectancy reduced.

Behavioural Phenotypes of Genetic Syndromes

These are the most frequently tested LD recall questions. The exam presents a brief clinical description and asks the candidate to identify the syndrome.

• Down syndrome (trisomy 21): The most common genetic cause of LD. Typical physical features: upslanting palpebral fissures, epicanthic folds, flat nasal bridge, protruding tongue, single palmar crease, hypotonia. Behavioural phenotype: friendly, sociable disposition, relative strength in social skills and visual-spatial abilities compared to language. Associated with Alzheimer’s disease (virtually all have Alzheimer pathology by age 40), congenital heart defects, hypothyroidism, leukaemia, atlantoaxial instability, and hearing/vision impairments. The gene for amyloid precursor protein (APP) is on chromosome 21, linking Down syndrome to early Alzheimer pathology.
• Fragile X syndrome (Martin-Bell): The most common inherited cause of LD. Caused by trinucleotide (CGG) repeat expansion on the X chromosome (FMR1 gene). More common and more severe in males (who have only one X chromosome). Physical features: long face, prominent ears, large testicles (macro-orchidism, post-pubertal). Behavioural phenotype: social anxiety, gaze aversion, ADHD features, autistic traits (up to 30% meet criteria for autism), hand flapping, and perseverative speech. Females with Fragile X tend to have milder LD or normal IQ with anxiety and shyness.
• Rett syndrome: Caused by MECP2 mutation on the X chromosome, almost exclusively in females (males are typically non-viable). Normal development for 6-18 months, then regression with loss of acquired skills (hand skills, language), acquired microcephaly, stereotypic hand-wringing/hand-washing movements, ataxia, breathing dysrhythmia (hyperventilation, breath-holding), and seizures. The regression and characteristic hand movements are pathognomonic. A recall question confirmed: “MECP2 gene — Rett syndrome.”
• Cri du chat syndrome (5p deletion): Deletion of short arm of chromosome 5. Physical features: severe LD, microcephaly, hypertelorism (wide-set eyes), and a distinctive high-pitched cat-like cry in infancy. Behavioural phenotype: hyperactivity, repetitive behaviours, self-injury. A recall question: “Very noisy kid, severe LD, hypertelorism” — Cri du chat.
• Prader-Willi syndrome (paternal 15q11 deletion): Deletion of the paternal copy of chromosome 15q11-q13 (the maternal copy is imprinted, so this deletion removes the only active copy). In infancy: hypotonia, poor feeding, failure to thrive. In childhood: hyperphagia (insatiable appetite), obesity, compulsive food-seeking. Behavioural phenotype: temper outbursts, skin picking (self-injury), obsessive-compulsive traits, and high pain threshold. Distinctive physical features: almond-shaped eyes, narrow temples, small hands and feet, hypogonadism.
• Angelman syndrome (maternal 15q11 deletion): The same genetic locus as Prader-Willi but the deletion is on the maternal chromosome. Normal development initially, then severe developmental delay, ataxia, seizures, and a characteristic happy demeanour with frequent laughter, hand-flapping, and excitability. “Happy puppet” was the older term (now considered pejorative).
• Williams syndrome (7q11 deletion): Distinctive “elfin” facies (small upturned nose, wide mouth, full lips, small chin), hypercalcaemia, and cardiovascular disease (supravalvular aortic stenosis). Behavioural phenotype: very sociable, verbally fluent (often articulate beyond their cognitive level), friendly, and musically talented. However, they have poor visuospatial skills, anxiety (especially social anxiety), and ADHD.
• Tuberous sclerosis (TSC1/TSC2): Autosomal dominant. Physical features: facial angiofibromas (adenoma sebaceum), hypopigmented ash-leaf spots, shagreen patches (connective tissue naevi on the lumbar region), and periungual fibromas. CNS: cortical tubers (hamartomas in the brain), subependymal nodules, and subependymal giant cell astrocytomas (SEGA). Associated with epilepsy (often infantile spasms), autism, ADHD, and LD of variable severity.
• Neurofibromatosis type 1 (NF1, 17q11): Autosomal dominant. Physical features: café-au-lait spots (>6, >5mm in children, >15mm in adults), axillary/inguinal freckling, neurofibromas, Lisch nodules (iris hamartomas), and optic pathway gliomas. Associated with LD (30-60%), ADHD, and social difficulties. A recall question confirmed: “Short, has freckles, Lisch nodules, LD” — Neurofibromatosis type 1.

Diagnostic Overshadowing

Diagnostic overshadowing is the tendency to attribute new symptoms (e.g., agitation, low mood, auditory hallucinations) to the person’s existing learning disability rather than recognising the possibility of a concurrent psychiatric disorder. This is a key concept tested in Paper B. It leads to underdiagnosis and undertreatment of mental health conditions in people with LD. People with LD have higher rates of psychiatric disorders than the general population (estimated 30-50% have a comorbid mental health condition, compared to 15-20% in the general population). The most common are: anxiety disorders, depression, schizophrenia (3-4 times higher), ADHD, and autism (which overlaps heavily with LD). Behavioural phenotypes and diagnostic overshadowing mean that mental illness in LD requires assessment by clinicians with specialist training. The Diagnostic Manual — Intellectual Disability (DM-ID) and the Royal College of Psychiatrists’ DC-LD provide adapted diagnostic criteria.

Mental Health in LD: Assessment and Management

Assessment of mental health in people with LD requires: obtaining collateral history (carers, family, support staff), observation over time, use of validated adapted assessment tools (PAS-ADD, Mini PAS-ADD, ABC — Aberrant Behaviour Checklist), and exclusion of physical causes (pain from constipation, dental caries, gastro-oesophageal reflux, epilepsy). The same NICE treatment guidelines apply for most conditions, but with adaptations: lower starting doses, slower titration, more careful monitoring of side effects, and involving the person’s support network in the treatment plan. Psychological interventions should be adapted to the person’s developmental level. People with LD are more vulnerable to medication side effects (especially antipsychotic-induced EPS and metabolic syndrome).

Atypical antipsychotics should NOT be used as chemical restraint for challenging behaviour without an appropriate psychiatric diagnosis. NICE (NG11) recommends a comprehensive behavioural assessment before prescribing and regular reviews with a plan to reduce or stop medication. This is a clinical governance priority.

Legal Framework for LD

The MCA 2005 is particularly relevant for people with LD, as many will lack capacity to make specific decisions. The functional test of capacity and best interests decision-making are the same as for other conditions, but the assessor must take into account the person’s communication needs and provide all practical support to enable them to participate in decision-making. The MHA 1983 can be used for people with LD who meet the criteria for detention — the Mental Health Act Code of Practice specifies that the MHA is preferred to the MCA for decisions about compulsory treatment of mental disorder. The MCA is used for decisions about care and treatment of physical health problems where the person lacks capacity. The interface between the two (Bournewood gap) was discussed in the old age psychiatry article. Safeguarding is critical: people with LD are at higher risk of abuse (physical, sexual, financial, institutional). Any concern must be referred to adult safeguarding under the Care Act 2014.

High-Yield Recall Patterns

• Most common inherited cause of LD: Fragile X syndrome (triplet repeat on X chromosome)
• Most common genetic cause of LD overall: Down syndrome (trisomy 21)
• MECP2 mutation: Rett syndrome (females, regression at 6-18mo, hand-wringing, microcephaly)
• 5p deletion: Cri du chat (cat-like cry, severe LD, hypertelorism, hyperactivity)
• 7q11 deletion: Williams syndrome (elfin facies, friendly/fluent, supravalvular aortic stenosis, hypercalcaemia)
• Paternal 15q11 deletion: Prader-Willi (hyperphagia, obesity, hypotonia, skin picking)
• Maternal 15q11 deletion: Angelman (happy puppet, seizures, ataxia, frequent laughter)
• NF1 triad: Short stature, café-au-lait spots, Lisch nodules, LD
• Diagnostic overshadowing: Attributing new psychiatric symptoms to the LD rather than recognising a treatable mental illness
• Down syndrome + Alzheimer’s: Virtually all have Alzheimer pathology by age 40. APP gene on chromosome 21.
• LD prevalence of psychiatric comorbidity: Approximately 30-50% (vs 15-20% general population)
• Antipsychotics in LD: Do NOT use for challenging behaviour without psychiatric diagnosis. NICE NG11.
• Sexual offending + LD: Antisocial PD + LD + substance abuse most commonly associated. Recall confirmed.
• Fetal alcohol syndrome: Microcephaly, growth retardation, distinct facies (smooth philtrum, thin upper lip). Recall confirmed.

PsychStar’s Paper B question bank covers learning disability with recall-calibrated questions. Start with 5 free questions at psychstar.io/try.